Trial intelligence / Profile preview

FLUAD vs Fluzone High-Dose in Older Adults

NCT03183908Phase 4Completed

Sponsor
Duke University
Start
Aug 2017
Primary completion
Feb 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Duke University. Started Aug 2017; status: completed.

02

Drugs

Fluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT03183908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03183908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call